AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP)
Launched by FUDAN UNIVERSITY · Jul 15, 2025
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Newly diagnosed prostate adenocarcinoma confirmed by histopathology;
- • 2. Age 18 years or older;
- • 3. Must be a candidate for radical prostatectomy, including but not limited to laparoscopic radical prostatectomy (LapRP) and robot-assisted radical prostatectomy (RARP);
- • 4. Ability to independently complete questionnaire filling and possess basic language comprehension ability;
- • 5. Ability to understand and willingness to sign informed consent.
- Exclusion Criteria:
- • 1. A history of severe diagnosed mental illness (such as depression, anxiety disorder, insomnia);
- • 2. A history of diagnosed cognitive dysfunction (such as intellectual disability, Parkinson's disease);
- • 3. Requires emergency surgery (within 72 hours after diagnosis);
- • 4. Has participated in other interventional clinical trials.
About Fudan University
Fudan University, a prestigious comprehensive research university located in Shanghai, China, is committed to advancing medical science through innovative clinical research. Renowned for its rigorous academic standards and cutting-edge research facilities, Fudan University plays a pivotal role in the global health landscape by sponsoring a diverse array of clinical trials aimed at improving patient outcomes and addressing pressing medical challenges. Leveraging its multidisciplinary expertise and collaborative networks, the university strives to translate scientific discoveries into practical applications, fostering advancements in healthcare and contributing to the well-being of communities both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, Shanghai, China
Patients applied
Trial Officials
Bo Dai, MD
Principal Investigator
Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported